Post-operative radiotherapy for Ewing sarcoma: When, how and how much?

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 575-580

  Laskar, S ^a   Mallick, I ^a   Gupta, T ^a   Muckaden, M A ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Ewing PNET; Histopathological response; Radiation therapy; Surgery

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; EVIDENCE BASED MEDICINE; EWING SARCOMA; HISTOPATHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING;

BONE NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; EVIDENCE-BASED MEDICINE; HUMANS; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; SARCOMA, EWING'S;

EID: 52249095913     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21657     Document Type: Review

References (39)

1. Dunst J, Sauer R, Burgers JM, et al. Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86. Cancer 1991;67:2818-2825.
2. Dunst J, Schuck A. Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer 2004;42:465-470.
3. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;153:106-120.
4. Ozaki T, Hillmann A, Hoffmann C, et al. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study. Cancer 1996; 78:892-900.
5. Bacci G, Longhi A, Briccoli A, et al. The role of surgical margins in treatment of Ewing's sarcoma family tumors: Experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2006; 65:766-772.
6. Sluga M, Windhager R, Lang S, et al. The role of surgery and resection margins in the treatment of Ewing's sarcoma. Clin Orthop Relat Res 2001:394-399.
7. Lin PP, Jaffe N, Herzog CE, et al. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer 2007;109:603-611.
8. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003;55:168-177.
9. Donaldson SS. Ewing sarcoma: Radiation dose and target volume. Pediatr Blood Cancer 2004;42:471-476.
10. Picci P, Bohling T, Bacci G, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997;15:1553-1559.
11. Wunder JS, Paulian G, Huvos AG, et al. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 1998;80:1020-1033.
12. Elomaa I, Blomqvist CP, Saeter G, et al. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. Eur J Cancer 2000;36:875-880.
13. Sluga M, Windhager R, Lang S, et al. A long-term review of the treatment of patients with Ewing's sarcoma in one institution. Eur J Surg Oncol 2001;27:569-573.
14. Oberlin O, Deley MC, Bui BN, et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: The third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 2001;85:1646-1654.
15. Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and1992. Eur J Cancer 2004;40:73-83.
16. Bolek TW, Marcus RB Jr, Mendenhall NP, et al. Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities. Int J Radiat Oncol Biol Phys 1996;35:687-692.
17. Merchant TE, Kushner BH, Sheldon JM, et al. Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma. Med Pediatr Oncol 1999;33:65-70.
18. Rosen G, Caparros B, Nirenberg A, et al. Ewing's sarcoma: Ten-year experience with adjuvant chemotherapy. Cancer 1981; 47:2204-2213.
19. Sauer R, Jurgens H, Burgers JM, et al. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. Radiother Oncol 1987;10:101-110.
20. Krasin MJ, Rodriguez-Galindo C, Davidoff AM, et al. Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors. Pediatr Blood Cancer 2004;43:229-236.
21. Dunst J, Jurgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 1995;32:919-930.
22. Rosito P, Mancini AF, Rondelli R, et al. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: A preliminary report of 6 years of experience. Cancer 1999;86:421-428.
23. Marcus RB Jr, Cantor A, Heare TC, et al. Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of bone. Int J Radiat Oncol Biol Phys 1991;21:1509-1515.
24. Schuck A, Rube C, Konemann S, et al. Postoperative radiotherapy in the treatment of Ewing tumors: Influence of the interval between surgery and radiotherapy. Strahlenther Onkol 2002;178:25-31.
25. Donaldson SS, Torrey M, Link MP, et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:125-135.
26. Arai Y, Kun LE, Brooks MT, et al. Ewing's sarcoma: Local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:1501-1508.
27. DeLaney TF, Trofimov AV, Engelsman M, et al. Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas. Cancer Control 2005;12:27-35.
28. Spierer MM, Alektiar KM, Zelefsky MJ, et al. Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys 2003;56: 1112-1116.
29. Jeys LM, Luscombe JS, Grimer RJ, et al. The risks and benefits of radiotherapy with massive endoprosthetic replacement. J Bone Joint Surg Br 2007;89:1352-1355.
30. Safran MR, Kody MH, Namba RS, et al. 151 endoprosthetic reconstructions for patients with primary tumors involving bone. Contemp Orthop 1994;29:15-25.
31. Hillmann A, Hoffmann C, Gosheger G, et al. Tumors of the pelvis: Complications after reconstruction. Arch Orthop Trauma Surg 2003;123:340-344.
32. Ham SJ, Schraffordt Koops H, Veth RP, et al. Limb salvage surgery for primary bone sarcoma of the lower extremities: Long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol 1998;5:423-436.
33. Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 2004;60:265-274.
34. Craft AW, Cotterill SJ, Bullimore JA, et al. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 1997;33:1061-1069.
35. Dunst J, Ahrens S, Paulussen M, et al. Second malignancies after treatment for Ewing's sarcoma: A report of the CESS-studies. Int J Radiat Oncol Biol Phys 1998;42:379-384.
36. Gasparini M, Lombardi F, Ballerini E, et al. Long-term outcome of patients with monostotic Ewing's sarcoma treated with combined modality. Med Pediatr Oncol 1994;23:406-412.
37. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14:2818-2825.
38. McLean TW, Hertel C, Young ML, et al. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: The Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol 1999;21:486-493.
39. Paulussen M, Ahrens S, Lehnert M, et al. Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol 2001;12:1619-1630.